| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | 56.5× | −1.7× | |
| Price / Book | 1.8× | 2.0× | |
| Price / Sales | — | 4.0× | — |
| Price / Free cash flow | −6.2× | −1.5× | |
| EV / EBITDA | −7.1× | −1.2× | |
| Earnings yield | 1.8% | −14.4% | |
| Free cash flow yield | −16.1% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,295.64 | +4.46% | $1.22T | 56.6× | 77.8% | +15.2% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $259.30 | +2.17% | $624.89B | 22.8× | 32.9% | +32.1% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $288.72 | +2.14% | $510.2B | 118.2× | −129.2% | +24.6% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $418.56 | +2.87% | $375.7B | 30.3× | 12.8% | +14.1% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $148.01 | +3.05% | $365.15B | 19.4× | 34.7% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $152.97 | +1.84% | $282B | 19.7× | 30.5% | +14.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $168.62 | +2.85% | $261.51B | 24.8× | 21.1% | −2.4% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $683.92 | +0.67% | $252.88B | 37.3× | 12.6% | +26.6% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $434.70 | +2.30% | $235.01B | 29.8× | 89.1% | +43.7% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $155.74 | +1.74% | $193.11B | 22.3× | 37.5% | +29.9% |
